February

Kids saying no to cigarettes are saying yes to vaping
In a study led by UNC Family Medicine’s Adam Goldstein, MD, researchers found that efforts are needed to help youth remain nicotine free – especially those adolescents who aren’t otherwise susceptible to smoking cigarettes.
The Right Note at the Right Time
One great performance earned Angela Smith a music scholarship to UNC. She’s been in Chapel Hill ever since. Now, as a urologic oncologist, she’s developing an app to ensure her patients get the right information, right on time. Her work has earned her a Jefferson-Pilot Fellowship in Academic Medicine.
Envisioning His Future
Qing Zhang earns a Jefferson-Pilot Fellowship in Academic Medicine for his work understanding oxygen’s role in therapy-resistant tumors.
A history of de-prescribing: Why UNC physicians’ approach to opioids is catching on
UNC’s Paul R. Chelminski, MD, MPH, and Timothy J. Ives, PharmD, MPH, CPP, have been sounding the alarm about proper opioid prescribing for decades. Now their treatment methods are the focus of a multi-institutional study on opioid use that could one day change how all health care providers approach chronic pain management.
UNC Lineberger researcher launches startup to improve radiation treatment in developing world
UNC Lineberger's Sha Chang, PhD, was named to the latest class of KickStart Venture Services' Commercialization Award winners. Her startup company is creating solutions for improving radiation treatment for cancer.
Gene therapy researchers find viral barcode to cross the blood-brain barrier
UNC School of Medicine scientists led by Aravind Asokan, PhD, reveal how certain gene-carrying AAV vectors can penetrate the brain more efficiently to treat brain and spinal cord conditions, while reducing liver payload.
Diering selected as finalist for Eppendorf & Science Prize for Neurobiology
The biotech company and top-tier science journal named Graham Diering, PhD, as one of three finalists whose essays on neurobiology were published in Science.
Integrated Care of Patients with Atrial Fibrillation Symposium, Hosted by UNC School of Medicine
Continuing Professional Education March 10th
UNC School of Medicine departments rank high on “Best Global Universities” list
In the annual U.S. News & World Report rankings, pharmacology and toxicology were lumped into one category and ranked first among public universities. Among all universities around the globe, UNC pharmacology/toxicology ranked second behind Harvard.
Scientists map molecular mechanisms crucial for new approach to heart disease therapy
Scientists led by UNC McAllister Heart Institute researcher Frank Conlon, PhD, reveal detailed molecular events underlying the transformation of ordinary fibroblast cells into therapeutic cardiac muscle cells.
HIV exports viral protein in cellular packages
A study from the lab of UNC Lineberger's Dirk Dittmer, PhD, found that HIV sends out a protein called Nef in cellular packages called exosomes.
Researchers define structure, function of enzyme key to blood cancers
In the journal Nature, UNC Lineberger's Greg Wang, PhD, and colleagues reported findings about the structure and function of the DNMT3A enzyme complex, which helps control gene expression.
Davis named Chair of Department of Pediatrics
Stephanie D. Davis, MD, has been appointed Chair of the Department of Pediatrics at the UNC School of Medicine and Physician in Chief of UNC Children’s Hospital effective July 23, 2018.
SHAC’s Mandarin Interpreting Service Helps Meet Growing Need
When the leaders of the student-run free clinic saw a rise in Mandarin speaking patients, they mobilized a group of undergraduate interpreters to make sure there were no gaps in patient care.
New therapeutic gel shows promise against cancerous tumors
The lab of Zhen Gu, PhD, in the joint UNC-NC State biomedical engineering department developed a biodegradable hydrogel scaffold system to release chemotherapeutic and immunotherapeutic drugs at the tumor site.
UNC SOM lands 16 departments in top 25 for NIH funding
The UNC School of Medicine ranks 16th overall in NIH funding; 6th among public universities. The department of cell biology and physiology is the highest ranked at 2nd overall.
Peanut allergy therapy proves effective during phase 3 clinical trial
Wesley Burks, MD, was a principal investigator on the phase 3 PALISADE trial to determine the efficacy of the AR101 oral immunotherapy developed by Aimmune Therapeutics for people allergic to peanuts.
Blue Cross Blue Shield invests $1.2 million to support UNC School of Medicine Physician Assistant Studies Program
Blue Cross NC announced continued investment in the two-year Physician Assistant Studies program, led by Paul Chelminski and housed in the Department of Allied Health Sciences.
Phase I clinical trial shows promise as investigational drug for melanoma
Three of 15 patients with BRAF-mutant melanoma had partial responses to an investigational compound in an early-stage study led by UNC Lineberger's Stergios Moschos, MD.
Share This: